Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE - Schedule of Antidilutive Securities (Details)

v3.22.2.2
NET LOSS PER SHARE - Schedule of Antidilutive Securities (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive securities (in shares) 60,000,034 36,399,373,000 60,000,034 22,971,164,000
Warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive securities (in shares) 12,521,494 10,870,308,000 12,521,494 3,623,436,000
Earnout Shares        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive securities (in shares) 9,000,000 7,813,187,000 9,000,000 2,604,396,000
RSUs        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive securities (in shares) 24,327,885 836,499,000 24,327,885 279,858,000
Stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive securities (in shares) 14,150,655 16,879,379,000 14,150,655 16,463,474,000